The Stop TB Partnership Working Group on New TB Vaccines presents the Tuberculosis Vaccine Candidates 2011, as an update of the 2009 Pipeline.

On March 8, and across the world the International Women's Day is being commemorated. Coincidentally, March is the global tuberculosis (TB) awareness month. The disease, which is caused by a mycrobatrium, has a major impact on women's sexual reproductive health and that of their children.

After seven years of research, the world's largest study of preventative tuberculosis (TB) therapy has found that untargeted, community-wide distribution of TB prevention drugs did not improve TB control on South African gold mines.

A renewed call for cheap tests that can rapidly identify resistant forms of the disease.

According to the District Health Barometer, TB and HIV are still the main causes of death. But the Barometer reveals that some districts have shown great improvements in tackling these diseases.

Updated WHO guidance launched today scales up effective public health interventions to reduce TB deaths for people living with HIV.

Dudley Lee's case reveals how overcrowding and a struggling court system are fuelling a TB epidemic.

A new paper outlining the pressing need for more advocacy efforts to address childhood TB has been published in the European Respiratory Journal.

The European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) agrees with the World Health Organization (WHO) dosing recommendations for ethambutol, isoniazid, pyrazinamide, and rifampicin as first-line antituberculosis medicines used in children, according to new EMA dosing guidelines released February 17.

TB/HIV co-infection represents a novel pathogenic scenario at the global level. Our knowledge about the mechanisms of interaction of the two pathogens still has many gaps that need to be filled in order to develop preventive measures against the two diseases.